{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:34:40Z","timestamp":1778186080157,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI16C0864"],"award-info":[{"award-number":["HI16C0864"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12906-019-2469-9","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T15:44:55Z","timestamp":1552578295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dual actions on gout flare and acute kidney injury along with enhanced renal transporter activities by Yokuininto, a Kampo medicine"],"prefix":"10.1186","volume":"19","author":[{"given":"Seung Hoon","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Sung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunhyuk","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Man","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7705-6593","authenticated-orcid":false,"given":"Dal-Seok","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"key":"2469_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nm1603","volume":"13","author":"CJ Chen","year":"2007","unstructured":"Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med. 2007;13:851\u20136.","journal-title":"Nat Med"},{"key":"2469_CR2","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s12272-010-1108-2","volume":"33","author":"J Feng","year":"2010","unstructured":"Feng J, Li X, Yang X, Zhang C, Yuan Y, Pu J, et al. A new practical system for evaluating the pharmacological properties of uricase as a potential drug for hyperuricemia. Arch Pharm Res. 2010;33:1761\u20139.","journal-title":"Arch Pharm Res"},{"key":"2469_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-015-0644-1","volume":"15","author":"N Amat","year":"2015","unstructured":"Amat N, Umar A, Hoxur P, Anaydulla M, Imam G, Aziz R, et al. Traditional Uighur Medicine Karapxa decoction, inhibits liver xanthine oxidase and reduces serum uric acid concentrations in hyperuricemic mice and scavenges free radicals in vitro. BMC Complement Altern Med. 2015;15:131. https:\/\/doi.org\/10.1186\/s12906-015-0644-1 .","journal-title":"BMC Complement Altern Med"},{"key":"2469_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.eujim.2018.05.011","volume":"20","author":"SH Lee","year":"2018","unstructured":"Lee SH, Park G, Kim SB, Oh DS. Uric acid-lowering effect and intestinal permeability of Kampo medicine, Hachimijiogan, Yokuininto and Goshakusan. Eur J Intern Med. 2018;20:193\u20139.","journal-title":"Eur J Intern Med"},{"key":"2469_CR5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.phymed.2010.03.003","volume":"17","author":"HP Ammon","year":"2010","unstructured":"Ammon HP. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine. 2010;17:862\u20137.","journal-title":"Phytomedicine."},{"key":"2469_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1472-6882-12-224","volume":"12","author":"SP Pimentel","year":"2012","unstructured":"Pimentel SP, Barrella GE, Casarin RC, Cirano FR, Casati MZ, Foglio MA, et al. Protective effect of topical Cordia verbenacea in a rat periodontitis model: immune-inflammatory, antibacterial and morphometric assays. BMC Complement Altern Med. 2012;12:224.","journal-title":"BMC Complement Altern Med"},{"key":"2469_CR7","doi-asserted-by":"publisher","unstructured":"Oh DR, Kim JR, Choi CY, Choi CH, Na CS, Kang BY, et al. Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1. BMC Complement Altern Med. 2019;19:10. https:\/\/doi.org\/10.1186\/s12906-018-2415-2 .","DOI":"10.1186\/s12906-018-2415-2"},{"key":"2469_CR8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","volume":"380","author":"R Bellomo","year":"2012","unstructured":"Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380:756\u201366.","journal-title":"Lancet"},{"key":"2469_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12906-017-2055-y","volume":"17","author":"SM Oh","year":"2017","unstructured":"Oh SM, Park G, Lee SH, Seo CS, Shin HK, Oh DS. Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure times. BMC Complement Altern Med. 2017;17:544.","journal-title":"BMC Complement Altern Med"},{"key":"2469_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12906-015-0817-y","volume":"15","author":"YH Wang","year":"2015","unstructured":"Wang YH, Liu YH, He GR, Lv Y, Du GH. Esculin improves dyslipidemia, inflammation and renal damage in streptozotocin-induced diabetic rats. BMC Complement Altern Med. 2015;15:402.","journal-title":"BMC Complement Altern Med"},{"key":"2469_CR11","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1172\/JCI75417","volume":"125","author":"L Yang","year":"2015","unstructured":"Yang L, Brooks CR, Xiao S, Sabbisetti V, Yeung MY, Hsiao LL, et al. KIM-1\u2013mediated phagocytosis reduces acute injury to the kidney. J Clin Invest. 2015;125:1620\u201336.","journal-title":"J Clin Invest"},{"key":"2469_CR12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bbrc.2007.10.103","volume":"364","author":"EW Kuehn","year":"2007","unstructured":"Kuehn EW, Hirt MN, John AK, Muehlenhardt P, Boehlke C, P\u00fctz M, et al. Kidney injury molecule 1(Kim1) is a novel ciliary molecule and interactor of polycystin 2. Biochem Biophys Res Commun. 2007;364:861\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"2469_CR13","unstructured":"Kosuke T, Tadahisd U, Toshikazu Y, Toru Y, Tadasho H, Kenro K. [Yokuininto (kampo medicine): a choice for mild to moderate osteoarthritis of the knee joint]. Kampo and the newest therapy 2007\u201302;16:61\u201366. (In Janpanese). http:\/\/ci.nii.ac.jp\/naid\/40015368083\/ ."},{"key":"2469_CR14","unstructured":"Toshiaki K, Atsushi N, Hiroshi F, Takahiro S, Yutaka S, Katsutoshi T. [The Consideration of the Patients with Rheumatoid Arthritis Successfully Treated with Yokuinin-to-kami]. Journal of the Japan Society for Oriental Medicine 2001;51:51\u201359."},{"key":"2469_CR15","unstructured":"Kracie Holdings,Ltd [ http:\/\/www.kracie.co.jp\/products\/ph\/1202036_2220.html ]. Accessed 7 Feb 2018."},{"key":"2469_CR16","unstructured":"Rakuten, Inc Rakuten Global Market [ https:\/\/global.rakuten.com\/en\/store\/yoikenkou\/item\/103-4987045046704_1\/ ]. Accessed 5 Mar 2019."},{"key":"2469_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2133\/dmpk.20.379","volume":"20","author":"N Kimura","year":"2005","unstructured":"Kimura N, Masuda S, Tanihara Y, Ueo H, Okuda M, Katsura T, et al. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. Drug Metab Pharmacokinet. 2005;20:379\u201386.","journal-title":"Drug Metab Pharmacokinet"},{"key":"2469_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.bcp.2015.08.099","volume":"98","author":"D Cihalova","year":"2015","unstructured":"Cihalova D, Ceckova M, Kucera R, Klimes J, Staud F. Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro. Biochem Pharmacol. 2015;98:465\u201372.","journal-title":"Biochem Pharmacol"},{"key":"2469_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1248\/jhs.53.77","volume":"53","author":"M Katakura","year":"2007","unstructured":"Katakura M, Kudo N, Tsuda T, Hibino Y, Mitsumoto A, Kawashima Y. Rat organic anion transporter 3 and organic anion transporting polypeptide 1 mediate perfluorooctanoic acid transport. Int J Health Sci Res. 2007;53:77\u201383. https:\/\/doi.org\/10.1248\/jhs.53.77 .","journal-title":"Int J Health Sci Res"},{"key":"2469_CR20","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/S0021-9258(18)91929-0","volume":"243","author":"JM McCord","year":"1968","unstructured":"McCord JM, Fridovich I. The reduction of cytochrome c by milk xanthine oxidase. J Biol Chem. 1968;243:5753\u201360.","journal-title":"J Biol Chem"},{"key":"2469_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMcp1001124","volume":"364","author":"T Neogi","year":"2011","unstructured":"Neogi T. Gout. N Engl J Med. 2011;364:443\u201352.","journal-title":"N Engl J Med"},{"key":"2469_CR22","first-page":"53","volume":"15","author":"F Haidari","year":"2009","unstructured":"Haidari F, Jr M, Shahi M, Keshavarz SA, Rashidi MR. Inhibitory Effects of Tart Cherry (Prunus cerasus) Juice on Xanthine Oxidoreductase Activity and its Hypouricemic and Antioxidant Effects on Rats. Malays J Nutr. 2009;15:53\u201364.","journal-title":"Malays J Nutr"},{"key":"2469_CR23","first-page":"231","volume":"66","author":"MH Pillinger","year":"2008","unstructured":"Pillinger MH, Keenan RT. Update on the management of hyperuricemia and gout. Bull NYU Hosp Jt Dis. 2008;66:231\u20139.","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"2469_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1142\/S0192415X14200018","volume":"42","author":"XH Wu","year":"2014","unstructured":"Wu XH, Yu CH, Zhang CF, Anderson S, Zhang YW. Smilax riparia reduces hyperuricemia in mice as a potential treatment of gout. Am J Chin Med. 2014;42:257\u20139.","journal-title":"Am J Chin Med"},{"key":"2469_CR25","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI42344","volume":"120","author":"A So","year":"2010","unstructured":"So A, Thorens B. Uric acid transport and disease. J Clin Invest. 2010;120:1791\u20139.","journal-title":"J Clin Invest"},{"key":"2469_CR26","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/art.10792","volume":"47","author":"F Perez-Ruiz","year":"2002","unstructured":"Perez-Ruiz F, Calabozo M, Erauskin GG, Ruibal A, Herrero-Beites AM. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum. 2002;47:610\u20133.","journal-title":"Arthritis Rheum"},{"key":"2469_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1152\/physiolgenomics.00207.2007","volume":"33","author":"SA Eraly","year":"2008","unstructured":"Eraly SA, Vallon V, Rieg T, Gangoiti JA, Wikoff WR, Siuzdak G, et al. Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics. 2008;33:180\u201392.","journal-title":"Physiol Genomics"},{"key":"2469_CR28","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.phymed.2014.03.009","volume":"21","author":"XH Wu","year":"2014","unstructured":"Wu XH, Zhang J, Wang SQ, Yang VC, Anderson S, Zhang YW. Riparoside B and timosaponin J, two steroidal glycosides from Smilax riparia, resist to hyperuricemia based on URAT1 in hyperuricemic mice. Phytomedicine. 2014;21:1196\u2013201.","journal-title":"Phytomedicine"},{"key":"2469_CR29","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1371\/journal.pgen.0030194","volume":"3","author":"S Li","year":"2007","unstructured":"Li S, Sanna S, Maschio A, Busonero F, Usala G, Mulas A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 2007;3:e194.","journal-title":"PLoS Genet"},{"key":"2469_CR30","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ng.107","volume":"40","author":"A D\u00f6ring","year":"2008","unstructured":"D\u00f6ring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Gene. 2008;40:430\u20136.","journal-title":"Nat Gene"},{"key":"2469_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12906-017-1698-z","volume":"17","author":"TD Nguyen","year":"2017","unstructured":"Nguyen TD, Thuong PT, Hwang IH, Hoang TK, Nguyen MK, Nguyen HA, et al. Anti-Hyperuricemic, Anti-Inflammatory and Analgesic Effects of Siegesbeckia orientalis L. Resulting from the Fraction with High Phenolic Content. BMC Complement Altern Med. 2017;17:191.","journal-title":"BMC Complement Altern Med"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2469-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-019-2469-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2469-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T20:36:17Z","timestamp":1663101377000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-019-2469-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2469"],"URL":"https:\/\/doi.org\/10.1186\/s12906-019-2469-9","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"10 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal maintenance and treatment were conducted in compliance with the Principles of Laboratory Animal Care. All animal procedures were approved by the institutional animal care and use committee of Korea Institute of Oriental Medicine (Approval No. KIOM #16\u2013069).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. The K-25 was donated by Kracie Pharma Korea Co., Ltd. (Seoul, Korea).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"57"}}